Immunome, Inc. (IMNM)
23.42
-0.53
(-2.21%)
USD |
NASDAQ |
Sep 16, 16:00
23.42
0.00 (0.00%)
After-Hours: 18:28
Immunome Total Assets (Quarterly) : 565.38M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 565.38M |
| March 31, 2026 | 619.79M |
| December 31, 2025 | 683.19M |
| September 30, 2025 | 299.38M |
| June 30, 2025 | 296.29M |
| March 31, 2025 | 342.69M |
| December 31, 2024 | 240.24M |
| September 30, 2024 | 256.90M |
| June 30, 2024 | 296.22M |
| March 31, 2024 | 319.75M |
| December 31, 2023 | 148.54M |
| September 30, 2023 | 93.16M |
| Date | Value |
|---|---|
| June 30, 2023 | 41.44M |
| March 31, 2023 | 48.11M |
| December 31, 2022 | 24.05M |
| September 30, 2022 | 30.55M |
| June 30, 2022 | 39.02M |
| March 31, 2022 | 47.73M |
| December 31, 2021 | 57.92M |
| September 30, 2021 | 62.56M |
| June 30, 2021 | 64.14M |
| March 31, 2021 | 42.59M |
| December 31, 2020 | 44.52M |
| September 30, 2020 | 11.98M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 15.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 40.30M |
| Shareholders Equity (Quarterly) | 525.08M |
| Debt to Equity Ratio | 0.009 |
| Current Ratio | 15.08 |
| Net Debt Paydown Yield | 0.00% |